More Accessible COVID-19 Treatment Through Monoclonal Antibody Infusion in the Emergency Department

INTRODUCTION: Monoclonal antibody (MAB) infusion is the first treatment to manage coronavirus 2019 (COVID-19) in an outpatient setting. Yet increased risk of severe COVID-19 illness may occur from inequities in social determinants of health including access to quality healthcare. Given the safety-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Heinert, Sara W., McCoy, Jonathan, Strickland, Pamela Ohman, Riggs, Renee, Eisenstein, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Department of Emergency Medicine, University of California, Irvine School of Medicine 2022
Materias:
Endemic Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541995/
https://www.ncbi.nlm.nih.gov/pubmed/36205670
http://dx.doi.org/10.5811/westjem.2022.5.55234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9541995/
https://www.ncbi.nlm.nih.gov/pubmed/36205670
http://dx.doi.org/10.5811/westjem.2022.5.55234

Ejemplares similares